What is the clinical evidence from this study?

Study design: Observational. Population: Patients with paired ECG and echocardiographic measurements to detect left ventricular hypertrophy and predict cardiovascular outcomes (n=47007). Intervention: Deep learning-enabled ECG system to detect LVH vs. Echocardiography-defined LVH (ECHO-LVH). Primary outcome: Incident cardiovascular outcomes including acute myocardial infarction (AMI), heart failure (HF), and atrial fibrillation (AFib) after LVH detection (Hazard ratios: AMI HR 2.67, HF HR 3.15, AFib HR 2.23 for AI-ECG-LVH compared to non-LVH; Echocardiography LVH HRs: AMI 2.76, HF 3.78, AFib 2.25).

What does this research mean for the field?

Deep learning-enabled ECG detection of left ventricular hypertrophy predicts incident acute myocardial infarction, heart failure, and atrial fibrillation with prognostic accuracy comparable to echocardiography. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To develop a deep learning model-enabled ECG system for detecting left ventricular hypertrophy (LVH) and evaluate its prognostic associations with incident cardiovascular outcomes.

March 7, 2026BioData MiningOpen Access

Deep learning-enabled ECG system for detecting left ventricular hypertrophy and predicting cardiovascular prognoses

View Full Paper

Ask AI

Bookmark

Key result

AI-ECG detection of LVH predicts major events comparably to echocardiography, including ~215% greater HF risk.

Why the study?

Conventional manual ECG criteria for LVH have limited sensitivity and suboptimal prognostic utility, prompting the development of a deep learning model-enabled ECG system for LVH detection and cardiovascular risk assessment.

Does a deep learning-enabled ECG system accurately detect left ventricular hypertrophy and predict incident acute myocardial infarction, heart failure, and atrial fibrillation compared to echocardiography?

Key Points

To develop a deep learning model-enabled ECG system for detecting left ventricular hypertrophy (LVH) and evaluate its prognostic associations with incident cardiovascular outcomes.
Retrospective cohort study using 40,736 patients from hospital A for development and internal validation (29,595 training, 5,935 tuning, and 5,206 internal validation) and 6,271 patients from hospital B for external validation.
LVH was defined using echocardiography-derived left ventricular mass index (LVMI).
Evaluated discrimination for LVH and assessed risk of incident acute myocardial infarction (AMI), heart failure (HF), and atrial fibrillation (AFib).
In external validation, the AI-ECG-LVH model achieved an AUC of 0.82 in males and 0.77 in females for detecting echocardiography-confirmed LVH.
Hazard ratios for incident outcomes predicted by AI-ECG-LVH were 2.67 for AMI, 3.15 for HF, and 2.23 for AFib, compared with 2.76, 3.78, and 2.25 for echocardiography-defined LVH.
In the external validation set, individuals with a severe AI-ECG-LVH signature had 6-year cumulative incidences of 7.2% for AMI, 30.9% for HF, and 22.4% for AFib, aligning closely with severe echocardiography-defined LVH (6.7%, 34.7%, and 23.3%, respectively).

Study Design

Type

Observational (n=47,007)

Multicenter

Yes

Structured PICO

Population

47,007 patients from two hospitals in Taipei, Taiwan. Hospital A (n=40,736) for model development and internal validation, and Hospital B (n=6,271) for external validation. Mean age 64-65 years, 50.4% male in validation sets.

Intervention

Deep learning model (DLM)-enabled 12-lead ECG system (AI-ECG-LVH) using standard 10-second, 500 Hz recordings

Comparator

Echocardiography-defined LVH (ECHO-LVH) and conventional automated ECG interpretation (Philips ECG system)

Outcome

Detection of left ventricular hypertrophy (LVMI >115 g/m2 in males, >95 g/m2 in females) and incident cardiovascular outcomes (new-onset acute myocardial infarction, heart failure, and atrial fibrillation)hard clinical

Main Result

Effect estimate: Hazard ratios: AMI HR 2.67, HF HR 3.15, AFib HR 2.23 for AI-ECG-LVH compared to non-LVH; Echocardiography LVH HRs: AMI 2.76, HF 3.78, AFib 2.25

An AI-enabled 12-lead ECG system can accurately detect left ventricular hypertrophy and provide long-term prognostic risk stratification for cardiovascular events that is comparable to echocardiography.

Limitations

Retrospective observational design limits causal inference
Lack of detailed demographic data such as age distribution and sex ratio
No reported confidence intervals or p-values for hazard ratios
Study conducted in Taiwan only may limit generalizability
No randomization or blinding in model evaluation
Validation was internal and external but within same hospital system

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Supports AI-ECG as practical alternative to echocardiography for LVH risk stratification; extends real-world prognostic evidence.

Cite This Study

Yang et al. (2026) conducted an observational in Patients with paired ECG and echocardiographic measurements to detect left ventricular hypertrophy and predict cardiovascular outcomes (n=47,007). Deep learning-enabled ECG system to detect LVH vs. Echocardiography-defined LVH (ECHO-LVH) was evaluated on Incident cardiovascular outcomes including acute myocardial infarction (AMI), heart failure (HF), and atrial fibrillation (AFib) after LVH detection (Hazard ratios: AMI HR 2.67, HF HR 3.15, AFib HR 2.23 for AI-ECG-LVH compared to non-LVH; Echocardiography LVH HRs: AMI 2.76, HF 3.78, AFib 2.25). Deep learning-enabled ECG detection of LVH predicted incident AMI, HF, and AFib with hazard ratios of 2.67, 3.15, and 2.23 respectively, comparable to echocardiography-defined LVH in 47,007 patients in Taiwan.

synapsesocial.com/papers/69abc0de5af8044f7a4e9919 https://doi.org/10.1186/s13040-026-00536-2

Topics

Echocardiography

View Full Paper

Ask AI

Bookmark